UBS Group AG - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 32 filers reported holding QUALIGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$16,000
+433.3%
56,777
+866.3%
0.00%
Q2 2022$3,000
-40.0%
5,876
-22.3%
0.00%
Q1 2022$5,000
-70.6%
7,563
-54.1%
0.00%
Q4 2021$17,0000.0%16,466
+25.5%
0.00%
Q3 2021$17,000
-15.0%
13,118
+30.7%
0.00%
Q2 2021$20,000
+25.0%
10,038
+70.6%
0.00%
Q1 2021$16,000
+128.6%
5,884
+138.5%
0.00%
Q4 2020$7,000
+40.0%
2,467
+130.8%
0.00%
Q3 2020$5,000
+150.0%
1,069
+99.1%
0.00%
Q2 2020$2,0005370.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders